Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
2,122,428
-
Shares change
-
+242,871
-
Total reported value, excl. options
-
$44,038,752
-
Value change
-
+$5,588,999
-
Number of buys
-
36
-
Number of sells
-
-12
-
Price
-
$20.75
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2018
53 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2018.
IRADIMED CORP - Common Stock (IRMD) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,122,428 shares
of 12,733,410 outstanding shares and own 16.67% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (288,566 shares), BlackRock Inc. (229,353 shares), VANGUARD GROUP INC (209,114 shares), Ranger Investment Management, L.P. (170,954 shares), Mondrian Investment Partners LTD (168,863 shares), CADENCE CAPITAL MANAGEMENT LLC (143,966 shares), RENAISSANCE TECHNOLOGIES LLC (117,200 shares), Russell Investments Group, Ltd. (88,223 shares), Menta Capital LLC (64,796 shares), and Boston Partners (62,658 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.